Nordic Countries Neurological Disease Market Analysis, Countries: Sweden, Norway, Denmark, Finland and others

Nordic Countries Neurological disease market size is estimated to be $XX million in 2022. One and a half percent of Finns have experienced a stroke. Although there has been a 50% decrease in stroke patient mortality since the 1970s, 1/5 of patients still pass away within 3 months of their stroke. The average patient’s lifetime medical expenses following a stroke are 86,300 euros. Two thirds of this amount, or 60,000 Euros, are directly attributable to stroke, and the remaining thirty percent is attributable to other illnesses. The annual cost of treating stroke patients in Finland accounts for 7% of all healthcare spending, or 1.1 billion euros.

In Finland, epilepsy affects close to 60,000 individuals, or around one in every 100 citizens. 36,000 of them regularly take medication for epilepsy. About 5,000 kids suffer from epilepsy. Around 3,000 people begin taking medication for epilepsy each year, 800 of whom are minors under the age of 15. Despite taking their medication, about one-third of epilepsy sufferers will still experience seizures.

A dementing disorder is yearly identified in more than 14,500 Finns. Estimates of the proportion of those over 65 and those in working age who have progressive memory impairments are included in this number. An estimated 200,000 people suffer from memory disorders.

According to the most recent WHO data, in 2020 Finland has a record of 11,120 or 23.00% mortalities from Alzheimer’s & Dementia. Finland ranks #1in the world with 54.65 per 100,000 people age adjusted death rate.

Neurological conditions can have a variety of causes, some of which include starvation, brain, spinal cord, or nerve damage. Infections, genetic illnesses, congenital anomalies or disorders, and lifestyle or environmental health problems may also be included. Numerous neurological conditions are recognized, some of which are uncommon but many of which are not. On the other hand, mental disorders are “psychiatric illnesses” or diseases that frequently manifest as aberrant thoughts, moods, or behavior that either cause distress or function.

Nordic Countries Neurological disease market by States

Sweden
Norway
Denmark
Finland
others

Nordic Countries Neurological disease market has been spilt into countries namely Sweden, Norway, Denmark, Finland and others.

Nordic Countries Neurological disease market Segments

Datavagyanik has covered each Neurological disease market in detail in terms of market size, sales volume, growth forecast. The segment and sub segment level categorization covered in the report are:

Nordic Countries Neurological disease market

Disease Type

Epilepsy
Alzheimer’s Disease
Parkinson’s Disease
Multiple Sclerosis
Cerebrovascular Disease

Drug Type

Cholinesterase Inhibitors
NMDA Receptor Antagonists
Antiepileptic
Antipsychotic and Antidepressant

Route of Drug

Oral
Parenteral

End-Users

Hospitals
Specialty Clinics
Homecare

Distribution Place

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Key questions answered in the Nordic Countries Neurological disease market Analysis Report:

What is the overall neurological disease market size in Nordic Countries and how is the demand rising?
What is the market size for Neurological disease in Nordic Countries?
Who are the top market players by market share, in each product segment?
Which is the fastest growing product segment?
What should be the business strategies and Go to Market strategies?

Neurological disease market in Nordic Countries: Report Deliverables

Summary Statistics
- Neurological disease market in Nordic Countries Market Attractiveness Analysis
Neurological disease market in Nordic Countries Market Analysis, by Segment (state level analysis)
- Overview
- Historical Market size ($Million), (2017 – 2021)
- Market size ($Million), and Forecasts (2022 – 2027)
Market Analysis by Segment (state level analysis)
Region wise analysis